agilon health, inc. (AGL) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-02

agilon health, inc. (AGL) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 3 Form 8-K material event filings were reported by AGL in the last 90 days. InsiderAlpha tracks every AGL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About agilon health, inc. (AGL)

SEC CIK	0001831097

90-Day SEC Filing Activity

Form 4 filings (90d)	10
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-07-02

Recent AGL Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-01	Schwaneke Jeffrey A.	Chief Financial Officer	F — Tax withholding / forfeiture	2.3K	$111.74	$258K	SEC
2026-06-02	WILLIAMS RONALD A	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-02	McLoughlin Karen	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-02	Battaglia Silvana	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-02	Mansukani Sharad	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-02	Wulf John William	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-02	MCKENZIE DIANA	Director	A — Grant or award	2.1K	$0.00	—	SEC
2026-06-01	Zamore Denise	Chief Legal Officer	F — Tax withholding / forfeiture	485	$92.54	$45K	SEC
2026-05-24	Gertsch Timothy	Chief Accounting Officer	F — Tax withholding / forfeiture	8	$86.39	$691	SEC
2026-05-07	O'Rourke Timothy Patrick	CEO & President	A — Grant or award	120.0K	$0.00	—	SEC
2026-05-07	O'Rourke Timothy Patrick	CEO & President	A — Grant or award	200.0K	$0.00	—	SEC
2026-04-15	Venkatachaliah Girish	Chief Technology Officer	F — Tax withholding / forfeiture	330	$26.88	$9K	SEC
2026-04-15	Gertsch Timothy	Chief Accounting Officer	F — Tax withholding / forfeiture	122	$26.88	$3K	SEC
2026-04-15	Zamore Denise	Chief Legal Officer	F — Tax withholding / forfeiture	220	$26.88	$6K	SEC
2026-04-15	Shaker Benjamin	Chief Markets Officer	F — Tax withholding / forfeiture	571	$26.88	$15K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for agilon health, inc. (AGL). Updated in real time as new filings are submitted to the SEC.

Most-Active AGL Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
O'Rourke Timothy Patrick	2	—
Battaglia Silvana	1	—
Schwaneke Jeffrey A.	1	$258K
Zamore Denise	1	$45K
Gertsch Timothy	1	$691

Recent AGL Form 8-K Material Events

2026-06-03 — Item 5.07 [SEC]
2026-05-06 — Item 2.02, 9.01 [SEC]
2026-04-27 — Item 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
Agilon Health appointed Tim O'Rourke as Chief Executive Officer and President, effective May 7, 2026. O'Rourke brings extensive healthcare industry experience from roles at Centene, Ascension, Humana, and most recently Help at Home LLC, and will also join the Board as a Class III
2026-03-30 — Item 3.03, 5.03, 9.01 · Restructuring · neutral [SEC]
Agilon Health completed a reverse stock split of its common stock on March 30, 2026, following stockholder approval at the March 17, 2026 Special Meeting. The Board was authorized to implement the split at a ratio between 1-for-5 and 1-for-25, with the Certificate of Amendment fi
2026-03-18 — Item 5.07, 8.01, 9.01 · Restructuring · negative [SEC]
Agilon Health's stockholders approved a reverse stock split at a ratio of 1-for-25, with the Board of Directors implementing this action effective March 30, 2026. Reverse stock splits are typically undertaken by companies facing delisting risk or seeking to improve stock price pe

Recent Insider Filings

2026-07-02 — Schwaneke Jeffrey A. (Chief Financial Officer)
2026-06-05 — Zamore Denise (Chief Legal Officer)
2026-06-05 — Wulf John William (Director)
2026-06-05 — WILLIAMS RONALD A (Director)
2026-06-05 — McLoughlin Karen (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AGL insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

AGL Insider Trading — FAQ

What is the latest insider trade for AGL?: agilon health, inc. (AGL) had 10 insider filings in the last 90 days, with the most recent on 2026-07-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AGL stock?: 0 insider purchases of AGL were filed in the last 90 days.
How many insiders are selling AGL stock?: 0 insider sales of AGL were filed in the last 90 days.
Where can I see AGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every AGL SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AGL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.